Abstract
Purpose of Review
To provide an updated overview of Photophobia with a particular focus on photophobia related to migraine.
Recent Findings
Melanopsin-containing photoreceptors called intrinsically photosensitive retinal ganglion cells (ipRGCs) have been identified in the retina and explain the rational for photophobia in individuals who are blind.
Summary
Photophobia, a sensory disturbance provoked by light, is a common neurological and ophthalmological symptom. Migraine, a common neurological condition, is pathognomonic of photophobia; however, other primary headache conditions, traumatic brain injury, and impairment of the optic pathway can cause photophobia. In addition, anterior and posterior segment ocular pathology, medications, and psychiatric conditions can result in photophobia. At least 2 (possibly three) distinct neural pathways are involved in photophobia. Some of the basic science regarding these pathways is discussed in this review including the role of calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide. Management of photophobia includes treatment of the underlying etiology and conservative strategies such as wearing sunglasses.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
HCCotI H. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;
Digre KB, Brennan K. Shedding light on photophobia. J Neuroophthalmol. 2012;32(1):68–81.
Rose FC. The history of migraine from Mesopotamian to medieval times. Cephalalgia. 1995;15(Suppl 15):1–3.
Ahn AH, Brennan K. Headache currents unanswered questions in headache. Headache. 2013;53(10):1673–4.
Lebensohn JE, Bellows J. The nature of photophobia. Arch Ophthalmol. 1934;12(3):380–90.
Cummings JL, Gittinger JW Jr. Central dazzle. A thalamic syndrome? Arch Neurol. 1981;38(6):372–4.
Wu Y, Hallett M. Photophobia in neurologic disorders. Translational Neurodegeneration. 2017;6:26.
Choi JY, Oh K, Kim BJ, Chung CS, Koh SB, Park KW. Usefulness of a photophobia questionnaire in patients with migraine. Cephalalgia : an International Journal of Headache. 2009;29(9):953–9.
Robbins MS, Lipton RB. The epidemiology of primary headache disorders. Semin Neurol. 2010;30(2):107–19.
Drummond PD, Woodhouse A. Painful stimulation of the forehead increases photophobia in migraine sufferers. Cephalalgia : an International Journal of Headache. 1993;13(5):321–4.
Vincent AJ, Spierings EL, Messinger HB. A controlled study of visual symptoms and eye strain factors in chronic headache. Headache. 1989;29(8):523–7.
Good PA, Taylor RH, Mortimer MJ. The use of tinted glasses in childhood migraine. Headache. 1991;31(8):533–6.
Drummond PD. A quantitative assessment of photophobia in migraine and tension headache. Headache: The Journal of Head and Face Pain. 1986;26(9):465–9.
Main A, Vlachonikolis I, Dowson A. The wavelength of light causing photophobia in migraine and tension-type headache between attacks. Headache. 2000;40(3):194–9.
Irimia P, Cittadini E, Paemeleire K, Cohen AS, Goadsby PJ. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia : an International Journal of Headache. 2008;28(6):626–30.
Cittadini E, Goadsby PJ. Hemicrania continua: a clinical study of 39 patients with diagnostic implications. Brain. 2010;133(Pt 7):1973–86.
Vanagaite J, Pareja JA, Storen O, White LR, Sand T, Stovner LJ. Light-induced discomfort and pain in migraine. Cephalalgia : an international journal of headache. 1997;17(7):733–41.
Vingen JV, Pareja JA, Stovner LJ. Quantitative evaluation of photophobia and phonophobia in cluster headache. Cephalalgia : an International Journal of Headache. 1998;18(5):250–6.
Kawasaki A, Kardon RH. Intrinsically photosensitive retinal ganglion cells. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 2007;27(3):195–204.
Provencio I, Jiang G, De Grip WJ, Hayes WP, Rollag MD. Melanopsin: an opsin in melanophores, brain, and eye. Proc Natl Acad Sci. 1998;95(1):340–5.
Xue T, Do MTH, Riccio A, Jiang Z, Hsieh J, Wang HC, et al. Melanopsin signaling in mammalian Iris and retina. Nature. 2011;479(7371):67–73.
Noseda R, Kainz V, Jakubowski M, Gooley JJ, Saper CB, Digre K, et al. A neural mechanism for exacerbation of headache by light. Nat Neurosci. 2010;13(2):239–45.
Johnson J, Wu V, Donovan M, Majumdar S, Renteria RC, Porco T, et al. Melanopsin-dependent light avoidance in neonatal mice. Proc Natl Acad Sci. 2010;107(40):17374–8.
Matynia A, Parikh S, Chen B, Kim P, McNeill DS, Nusinowitz S, et al. Intrinsically photosensitive retinal ganglion cells are the primary but not exclusive circuit for light aversion. Exp Eye Res. 2012;105:60–9.
Okamoto K, Thompson R, Tashiro A, Chang Z, Bereiter DA. Bright light produces Fos-positive neurons in caudal trigeminal brainstem. Neuroscience. 2009;160(4):858–64.
Maleki N, Becerra L, Upadhyay J, Burstein R, Borsook D. Direct optic nerve pulvinar connections defined by diffusion MR tractography in humans: implications for photophobia. Hum Brain Mapp. 2012;33(1):75–88.
Dolgonos S, Ayyala H, Evinger C. Light-induced trigeminal sensitization without central visual pathways: another mechanism for photophobia. Invest Ophthalmol Vis Sci. 2011;52(11):7852–8.
Burstein R, Yamamura H, Malick A, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol. 1998;79(2):964–82.
Noseda R, Burstein R. Advances in understanding the mechanisms of migraine-type photophobia. Curr Opin Neurol. 2011;24(3):197–202.
Amini A, Digre K, Couldwell WT. Photophobia in a blind patient: an alternate visual pathway. Case report J Neurosurg. 2006;105(5):765–8.
• Rossi HL, Recober A. Photophobia in primary headaches. Headache. 2015;55(4):600–. Excellent review of the pathways involved with photophobia including second, third and fourth order neurons as well as calcitonin gene related peptide and pituitary adenylate cyclase-activating polypeptide.–4.
Sprenger T, Goadsby PJ. Migraine pathogenesis and state of pharmacological treatment options. BMC Med. 2009;7(1):71.
Kaiser EA, Kuburas A, Recober A, Russo AF. Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist. J Neurosci. 2012;32(44):15439–49.
Markovics A, Kormos V, Gaszner B, Lashgarara A, Szoke E, Sandor K, et al. Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice. Neurobiol Dis. 2012;45(1):633–44.
Evans RW, Seifert T, Kailasam J, Mathew NT. The use of questions to determine the presence of photophobia and phonophobia during migraine. Headache: The Journal of Head and Face Pain. 2008;48(3):395–7.
Bossini LVM, Padula L, De Capua A, Pacchierotti C. P C. Sensibilità alla luce e psicopatologia: validazione del Questionario per la Valutazione della Fotosensibilità (QVF). Medicina Psicosomatica. 2006;51:167–76.
Edvinsson L, Villalon CM, MaassenVanDenBrink A. Basic mechanisms of migraine and its acute treatment. Pharmacol Ther. 2012;136(3):319–33.
Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22(5):345–53.
Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257–63.
Koseoglu E, Talaslioglu A, Gonul AS, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magnes Res. 2008;21(2):101–8.
von Luckner A, Riederer F. Magnesium in migraine prophylaxis-is there an evidence-based rationale? A systematic review. Headache. 2018;58(2):199–209.
Diel RJ, Kroeger ZA, Levitt RC, Sarantopoulos C, Sered H, Martinez-Barrizonte J, et al. Botulinum toxin a for the treatment of photophobia and dry eye. Ophthalmology. 2018;125(1):139–40.
• Katz BJ, Digre KB. Diagnosis, pathophysiology, and treatment of photophobia. Surv Ophthalmol. 2016;61(4):466–. This review article discusses melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) as a culprit in photophobia.–77.
Karanovic O, Thabet M, Wilson HR, Wilkinson F. Detection and discrimination of flicker contrast in migraine. Cephalalgia. 2011;31(6):723–36.
Hallett M, Evinger C, Jankovic J, Stacy M. Update on blepharospasm: report from the BEBRF International Workshop. Neurology. 2008;71(16):1275–82.
Blackburn MK, Lamb RD, Digre KB, Smith AG, Warner JE, McClane RW, et al. FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology. 2009;116(5):997–1001.
Fine PG, Digre KB. A controlled trial of regional sympatholysis in the treatment of photo-oculodynia syndrome. J Neuroophthalmol. 1995;15(2):90–4.
Young W, Cook B, Malik S, Shaw J, Oshinsky M. The first 5 minutes after greater occipital nerve block. Headache. 2008;48(7):1126–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Abdul Albilali declares no conflict of interest.
Esma Dilli has received honoraria from Allergan and paid travel accommodations from Novartis.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Headache
Rights and permissions
About this article
Cite this article
Albilali, A., Dilli, E. Photophobia: When Light Hurts, a Review. Curr Neurol Neurosci Rep 18, 62 (2018). https://doi.org/10.1007/s11910-018-0864-0
Published:
DOI: https://doi.org/10.1007/s11910-018-0864-0